Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Blepharoptosis Development in Patients Undergoing Repeated Intravitreal Anti-VEGF Injections

NCT07821450 is registered in ClinicalTrials.gov with Abdulkadir Küçük as lead sponsor.

NCT NCT07821450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07821450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Blepharoptosis Development in Patients Undergoing Repeated Intravitreal Anti-VEGF Injections
Lead sponsor
Abdulkadir Küçük
Phase
Observational
Overall status
Not yet recruiting
Start date
September 25, 2026
Completion date
January 5, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, blepharoptosis, diabetic macular edema